Concepedia

Genevieve Meier

GM

17

Publications

629

Citations

13

H-Index

2012

Active since

Affiliations

GlaxoSmithKline (Belgium)(Current)

Eisai (United States)

RTI Health Solutions

GlaxoSmithKline (Canada)

Kindai University

Genevieve Meier is an author at GlaxoSmithKline (Belgium) specializing in medicine, epidemiology, and vaccination.

Top concepts

MedicineVaccinationEpidemiologyPublic HealthInfluenza VaccinesPreventive MedicineVaccine SafetyHealth EconomicsVaccine EfficacyEgg-based Vaccine Production

Publications per year

2012–2021

17

Publications

17

Lenvatinib versus sorafenib for first-line treatment of unresectable hepatocellular carcinoma: patient-reported outcomes from a randomised, open-label, non-inferiority, phase 3 trial

Arndt Vogel, Shukui Qin, Masatoshi Kudo et al. · The Lancet. Gastroenterology & hepatology · 2021 · 139 citations

Patient-reported Outcomes, Hepatology, Medicine +10

Cost-effectiveness analysis of lenvatinib treatment for patients with unresectable hepatocellular carcinoma (uHCC) compared with sorafenib in Japan

Masahiro Kobayashi, Masatoshi Kudo, Namiki Izumi et al. · Journal of Gastroenterology · 2019 · 79 citations · Full text

The Potential Cost-Effectiveness of Quadrivalent versus Trivalent Influenza Vaccine in Elderly People and Clinical Risk Groups in the UK: A Lifetime Multi-Cohort Model

Laure-Anne Van Bellinghen, Genevieve Meier, Ilse Van Vlaenderen · PLoS ONE · 2014 · 67 citations · Full text

Cost-effectiveness analysis of universal influenza vaccination with quadrivalent inactivated vaccine in the United States

Karen M. Clements, Genevieve Meier, Lisa J. McGarry et al. · Human Vaccines & Immunotherapeutics · 2014 · 59 citations · Full text

Cost-effectiveness analysis of quadrivalent influenza vaccination in at-risk adults and the elderly: an updated analysis in the UK

Genevieve Meier, M. Gregg, B Poulsen Nautrup · Journal of Medical Economics · 2015 · 47 citations

Rows per page

1–5 of 17